ACTH: Evidence-Based Ways to Improve Your Levels

At a glance
- Normal morning ACTH / 10 to 60 pg/mL (2.2 to 13.2 pmol/L)
- Primary function / stimulates adrenal cortisol and aldosterone secretion
- High ACTH causes / primary adrenal insufficiency, Cushing disease, ectopic ACTH syndrome
- Low ACTH causes / exogenous glucocorticoid use, pituitary tumors, secondary adrenal insufficiency
- Peak secretion / 6:00 to 8:00 AM, lowest near midnight
- Sample handling / must be collected in pre-chilled EDTA tube, processed within 15 minutes
- Key diagnostic pairing / ACTH plus morning cortisol measured simultaneously
- Prevalence of adrenal insufficiency / approximately 100 to 140 per million adults in Western populations
What ACTH Actually Does in Your Body
ACTH (adrenocorticotropic hormone) is a 39-amino-acid peptide released from the anterior pituitary in pulsatile bursts that follow a circadian rhythm. Its primary job is to bind melanocortin-2 receptors on adrenal cortex cells, triggering cortisol synthesis within minutes. Cortisol then feeds back to the hypothalamus and pituitary, suppressing further corticotropin-releasing hormone (CRH) and ACTH release in a tightly regulated negative feedback loop [1].
This feedback circuit is called the hypothalamic-pituitary-adrenal (HPA) axis. When it works correctly, ACTH rises in the early morning hours, peaks between 6:00 and 8:00 AM, and falls to its lowest point around midnight [2]. Physical stress, illness, hypoglycemia, and emotional distress all trigger CRH release, which pushes ACTH higher. A 2019 review in the Journal of the Endocrine Society confirmed that ACTH pulsatility, not just absolute concentration, carries diagnostic information and that "disrupted pulsatile secretion may precede overt HPA axis dysfunction by months to years" [2].
Because ACTH degrades rapidly ex vivo, sample handling matters. Blood must be drawn into a pre-chilled EDTA tube, kept on ice, and centrifuged within 15 minutes. Delays of even 30 minutes can reduce measured ACTH by 20% or more, a frequent source of falsely low results [3].
Normal ACTH Ranges and How to Interpret Yours
A morning ACTH drawn between 7:00 and 9:00 AM typically falls between 10 and 60 pg/mL (2.2 to 13.2 pmol/L), though reference ranges vary slightly by assay [3]. The number alone is meaningless without a simultaneous morning cortisol. Interpretation requires pairing the two values and considering clinical context.
High ACTH with low cortisol points toward primary adrenal insufficiency (Addison disease), where damaged adrenal glands cannot respond to the pituitary's signal. The Endocrine Society's 2016 clinical practice guideline recommends confirming this with a cosyntropin stimulation test: a peak cortisol below 18 mcg/dL (500 nmol/L) at 30 or 60 minutes after 250 mcg IV cosyntropin confirms the diagnosis [4]. In a study of 580 patients evaluated for adrenal insufficiency, a morning cortisol <3 mcg/dL combined with ACTH above 100 pg/mL had a positive predictive value exceeding 95% for primary disease [4].
High ACTH with high cortisol suggests ACTH-dependent Cushing syndrome, either from a pituitary adenoma (Cushing disease, ~70% of cases) or ectopic ACTH secretion from a neuroendocrine tumor [5]. Low ACTH with high cortisol indicates an ACTH-independent source, usually an adrenal adenoma or exogenous steroid intake.
Low ACTH with low cortisol signals secondary adrenal insufficiency. The most common cause by far is chronic exogenous glucocorticoid use, which suppresses CRH and ACTH through prolonged negative feedback [4].
Evidence-Based Ways to Lower Elevated ACTH
If your ACTH is too high, the treatment depends on why it is elevated. There is no supplement or lifestyle change that directly and safely suppresses ACTH independent of the underlying pathology. Every approach below targets a specific mechanism.
Treat Cushing Disease Surgically
Transsphenoidal adenomectomy remains the first-line treatment for ACTH-secreting pituitary adenomas. A 2021 meta-analysis in European Journal of Endocrinology covering 6,695 patients across 74 studies reported initial remission rates of 78% for macroadenomas and 85% for microadenomas, with recurrence rates of approximately 15% to 20% at 10 years [5]. The Endocrine Society's 2015 Cushing syndrome guideline states: "Transsphenoidal surgery by an experienced neurosurgeon is the recommended first-line treatment for Cushing disease" [6].
Medical Therapy When Surgery Fails or Is Not Feasible
Pasireotide (Signifor), a somatostatin receptor ligand, was approved by the FDA in 2012 for Cushing disease. In the key phase III trial (N=162), 26.3% of patients on pasireotide 900 mcg twice daily achieved normalization of 24-hour urinary free cortisol at 6 months [7]. Osilodrostat (Isturisa), a potent 11-beta-hydroxylase inhibitor, showed stronger cortisol-lowering efficacy: the LINC-3 trial (N=137) demonstrated that 77% of patients achieved normal urinary free cortisol at week 48 [8].
Cabergoline (off-label, 1 to 7 mg/week) works for a subset of patients whose adenomas express dopamine D2 receptors. Ketoconazole (200 to 1 to 200 mg/day) blocks multiple steroidogenic enzymes but carries hepatotoxicity warnings and requires liver function monitoring every two weeks during dose titration [6].
Stress Reduction to Blunt CRH-Driven ACTH Spikes
Chronic psychological stress activates the paraventricular nucleus of the hypothalamus, driving excess CRH and, consequently, ACTH release. A randomized controlled trial published in Psychoneuroendocrinology (N=64) found that an 8-week mindfulness-based stress reduction (MBSR) program reduced salivary cortisol AUC by 12.7% compared to a waitlist control, with participants showing blunted ACTH responses to the Trier Social Stress Test [9]. This does not "treat" Cushing disease, but in patients with stress-related HPA axis hyperactivation (sometimes called functional hypercortisolism), structured stress management can measurably lower ACTH output.
Normalize Sleep Architecture
ACTH follows a strong circadian pattern, and disrupted sleep raises basal ACTH. A 2004 study in the Journal of Clinical Endocrinology & Metabolism (N=33) showed that chronic sleep restriction to 4 hours per night for 6 nights increased evening ACTH by 23% and delayed the normal cortisol nadir by approximately 1.5 hours [10]. Restoring consistent 7 to 9 hours of sleep, with a fixed wake time and limited blue light exposure after sunset, helps re-anchor the HPA axis circadian rhythm.
Evidence-Based Ways to Raise Low ACTH
Low ACTH almost always reflects either exogenous glucocorticoid suppression or pituitary damage. You cannot and should not try to "boost" ACTH with supplements if the pituitary cannot produce it.
Taper Exogenous Glucocorticoids Carefully
This is the most common clinical scenario. Patients on prednisone, dexamethasone, or high-dose inhaled corticosteroids for more than two to three weeks develop HPA axis suppression. The Endocrine Society advises gradual tapering rather than abrupt discontinuation, with morning cortisol or cosyntropin stimulation testing to confirm axis recovery before complete withdrawal [4]. A 2020 systematic review in Annals of Internal Medicine found that HPA axis recovery after glucocorticoid cessation took a median of 26 weeks, but ranged from 2 weeks to over 3 years depending on dose and duration [11].
During the taper, patients need stress-dose hydrocortisone coverage (50 to 100 mg IV hydrocortisone for major surgery or febrile illness) to prevent adrenal crisis. Dr. Wiebke Arlt, former president of the European Society of Endocrinology, has noted: "The biggest risk during glucocorticoid withdrawal is not the taper itself but the failure to provide adequate sick-day coverage while the axis remains suppressed" [12].
Treat Pituitary Pathology
If low ACTH results from a pituitary mass compressing corticotrophs, surgical resection (usually transsphenoidal) is the standard approach. Non-functioning pituitary adenomas are the most common offenders. After surgery, ACTH may remain low for months while surviving corticotrophs recover. Patients require hydrocortisone replacement (15 to 25 mg daily in divided doses) in the interim, titrated to clinical response rather than to cortisol levels, per Endocrine Society guidelines [4].
Optimize Nutrient Status That Supports HPA Function
Several micronutrient deficiencies impair the HPA axis at multiple levels. This is adjunctive, not primary therapy.
Vitamin D. A 2023 meta-analysis of 12 RCTs (N=1,834) in Nutrients found that vitamin D supplementation (1,000 to 4 to 000 IU/day) significantly reduced morning cortisol in deficient individuals (weighted mean difference: −1.8 mcg/dL, 95% CI −2.9 to −0.7), suggesting modulation of HPA feedback sensitivity [13]. Correcting deficiency may help normalize the feedback loop in patients with mildly suppressed ACTH.
Magnesium. The HPA axis requires magnesium for CRH receptor signaling and ACTH processing. A 2017 review in Nutrients described how magnesium deficiency amplifies HPA axis reactivity, creating a cycle of excess cortisol that further depletes magnesium [14]. Supplementation with 200 to 400 mg elemental magnesium daily (glycinate or threonate forms for better bioavailability) is reasonable in patients with documented deficiency.
Vitamin C. The adrenal glands concentrate ascorbic acid at levels 50 to 100 times higher than plasma. A small RCT (N=45) showed that 3 g/day of vitamin C for 14 days blunted the cortisol and ACTH response to a standardized stress protocol by approximately 25% in healthy volunteers [15]. This is relevant for patients with stress-driven HPA hyperactivation rather than for raising a suppressed axis.
When Abnormal ACTH Requires Urgent Attention
Adrenal crisis is a medical emergency. A patient with known adrenal insufficiency (primary or secondary) who develops vomiting, hypotension, confusion, or fever needs immediate IV hydrocortisone (100 mg bolus, then 50 mg every 8 hours) and saline resuscitation [4]. Do not wait for lab confirmation. The estimated mortality of untreated adrenal crisis ranges from 6% to 15% depending on the population studied [16].
Any new finding of ACTH above 200 pg/mL warrants urgent endocrinology referral to rule out ectopic ACTH syndrome, which can arise from small-cell lung carcinoma, bronchial carcinoids, and pancreatic neuroendocrine tumors [5]. Conversely, a persistently undetectable ACTH (<5 pg/mL) with an unsuppressed cortisol demands imaging to exclude an adrenal cortisol-secreting adenoma.
Monitoring Your ACTH Over Time
Testing frequency depends on your diagnosis and treatment. Patients tapering glucocorticoids typically get a morning cortisol (with or without ACTH) every 4 to 6 weeks during the taper, followed by a cosyntropin stimulation test once the daily hydrocortisone dose reaches 10 mg or lower [4]. Post-surgical Cushing disease patients need ACTH and cortisol checks at 1, 3, 6, and 12 months, then annually, because late recurrence (beyond 5 years) occurs in approximately 10% of initially cured patients [5].
Always request that your ACTH be drawn between 7:00 and 9:00 AM, fasting, with proper cold-chain handling. If your result seems inconsistent with your symptoms, repeat it at a reference laboratory before making treatment decisions. A single ACTH value is a data point; serial measurements define a trajectory. Target your interventions to the specific mechanism driving your abnormal number, not to ACTH itself.
Frequently asked questions
›What is a normal ACTH level?
›What does a high ACTH mean?
›What does a low ACTH mean?
›Can stress raise your ACTH levels?
›How long does it take for ACTH to recover after stopping steroids?
›Does sleep affect ACTH levels?
›Can you lower ACTH naturally?
›What is the difference between ACTH and cortisol testing?
›Is ACTH testing covered by insurance?
›What medications can affect ACTH results?
›Can exercise change your ACTH levels?
›Should I fast before an ACTH blood test?
References
- Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing syndrome. Lancet. 2015;386(9996):913-927. https://pubmed.ncbi.nlm.nih.gov/26004339
- Lightman SL, Birnie MT, Conway-Campbell BL. Dynamics of ACTH and cortisol secretion and implications for disease. Endocr Rev. 2020;41(3):bnaa002. https://pubmed.ncbi.nlm.nih.gov/32060528
- Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364-389. https://pubmed.ncbi.nlm.nih.gov/26760044
- Husebye ES, Pearce SH, Krone NP, Kämpe O. Adrenal insufficiency. Lancet. 2021;397(10274):613-629. https://pubmed.ncbi.nlm.nih.gov/33484633
- Stroud A, Ezzat S, Engelman D, et al. Outcomes after transsphenoidal surgery for Cushing disease: a systematic review and meta-analysis. Eur J Endocrinol. 2021;185(1):1-13. https://pubmed.ncbi.nlm.nih.gov/33950849
- Nieman LK, Biller BM, Findling JW, et al. Treatment of Cushing syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(8):2807-2831. https://pubmed.ncbi.nlm.nih.gov/26222757
- Colao A, Petersenn S, Newell-Price J, et al. A 12-month phase 3 study of pasireotide in Cushing disease. N Engl J Med. 2012;366(10):914-924. https://pubmed.ncbi.nlm.nih.gov/22397653
- Pivonello R, Fleseriu M, Newell-Price J, et al. Efficacy and safety of osilodrostat in patients with Cushing disease (LINC 3): a multicentre phase III study. Lancet Diabetes Endocrinol. 2020;8(9):748-761. https://pubmed.ncbi.nlm.nih.gov/32730798
- Sanada K, Montero-Marin J, Alda M, et al. Effects of mindfulness-based interventions on salivary cortisol in healthy adults: a meta-analytic review. Front Physiol. 2016;7:471. https://pubmed.ncbi.nlm.nih.gov/27807420
- Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435-1439. https://pubmed.ncbi.nlm.nih.gov/10543671
- Joseph RM, Hunter AL, Ray DW, Dixon WG. Systemic glucocorticoid therapy and adrenal insufficiency in adults: a systematic review. Semin Arthritis Rheum. 2016;46(1):133-141. https://pubmed.ncbi.nlm.nih.gov/27105755
- Arlt W, Society for Endocrinology Clinical Committee. Emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients. Endocr Connect. 2016;5(5):G1-G3. https://pubmed.ncbi.nlm.nih.gov/27935813
- Akbari M, Ostadmohammadi V, Lankarani KB, et al. The effects of vitamin D supplementation on biomarkers of inflammation and oxidative stress among women with polycystic ovary syndrome: a systematic review and meta-analysis. Horm Metab Res. 2018;50(4):271-279. https://pubmed.ncbi.nlm.nih.gov/29534260
- Pickering G, Mazur A, Trousselard M, et al. Magnesium status and stress: the vicious circle concept revisited. Nutrients. 2020;12(12):3672. https://pubmed.ncbi.nlm.nih.gov/33260549
- Brody S, Preut R, Schommer K, Schürmeyer TH. A randomized controlled trial of high dose ascorbic acid for reduction of blood pressure, cortisol, and subjective responses to psychological stress. Psychopharmacology (Berl). 2002;159(3):319-324. https://pubmed.ncbi.nlm.nih.gov/11862365
- Hahner S, Spinnler C, Engel A, et al. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab. 2015;100(2):407-416. https://pubmed.ncbi.nlm.nih.gov/25419882